Recent Searches
Dan is a senior advisor with more than 25 years of experience advising private equity firms, startups and established companies on growth strategy, business plan development, portfolio optimization, and mergers and acquisitions. He currently leads the EY-Parthenon Health and Life Sciences Private Equity team and previously served as an office leader for the EY-Parthenon New York office.
Dan has held strategic leadership roles at leading corporate and consulting organizations. In addition to leading over 500 buy and sell side commercial diligence engagements, Dan has extensive experience working for both private equity and corporate clients on strategy and transaction engagements involving multi-site providers, academic medical centers, hospital services, pharmacies, insurers, healthcare technology, revenue cycle management, medical devices and specialty pharmaceuticals.
He holds an MBA from Stanford University and a BA in Biology from the University of Pennsylvania, where he was a Benjamin Franklin Scholar and elected to the Phi Beta Kappa Society.
“I advise private equity firms, corporations, associations and investors seeking to improve the quality and reduce the cost of healthcare delivery. My teams develop information and insights that help EY-Parthenon clients assess investment opportunities and make the right strategic decisions in entering new markets, geographies and customer segments, or in buying or selling a business.
It is guidance grounded in objective analysis, shaped collaboratively by our experienced teams and the insights and perspectives of the clients. When investors acquire and build businesses that transform healthcare, they build a better working world.”
